We are live on !
Find out more
AM
Anqa Management Portfolio holdings
AUM
$66.5M
Turnover
28.57%
1-Year Est. Return
36.45%
This Fund
S&P 500
This Quarter Est. Return
-4.61%
1 Year Est. Return
+36.45%
3 Year Est. Return
+170.71%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$66.5M
AUM Growth
-$23.2M
(-26%)
Cap. Flow
-$18.7M
Cap. Flow % of AUM
Cap. Flow %
-28.16%
Top 10 Holdings %
Top 10 Hldgs %
98.81%
Holding
14
New
1
Increased
1
Reduced
4
Closed
3
Avg Time Held
1.2
years
Top 10 Avg Time Held
0.7
years
Top 20 Avg Time Held
1.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Enfusion, Inc.
ENFN
|
+$2.48M |
| 2 |
Illumina
ILMN
|
+$423K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AFTR.U
AfterNext HealthTech Acquisition Corp Units
AFTR.U
|
+$8.87M |
| 2 |
BKI
Black Knight, Inc. Common Stock
BKI
|
+$6.94M |
| 3 |
ATVI
Activision Blizzard
ATVI
|
+$3.58M |
| 4 |
InterDigital
IDCC
|
+$1.68M |
| 5 |
Pitney Bowes
PBI
|
+$524K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 34.93% |
| 2 | Technology | 34.5% |
| 3 | Communication Services | 15.67% |
| 4 | Industrials | 14.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Indivior Pharmaceuticals
INDV
$4B
| $17.5M | 26.29% |
805,446
| – | – |
2023 Q2
1 quarter
|
|
|
LGF.B
2
DELISTED
Lions Gate Entertainment Corp. Class B Non-Voting Shares
LGF.B
| $10.4M | 15.67% |
1,324,388
| – | – |
2022 Q2
5 quarters
|
|
|
SCPL
3
DELISTED
SciPlay Corporation Class A Common Stock
SCPL
| $9.11M | 13.69% |
400,000
| – | – |
2022 Q1
6 quarters
|
|
4
DELISTED
Spirit Airlines, Inc.
SAVE
| $7.32M | 10.99% |
443,307
| – | – |
2022 Q2
5 quarters
|
|
|
5
Illumina
ILMN
$39.7B
| $4.96M | 7.45% |
37,111
+2,570
| +7% | +$423K |
2023 Q2
1 quarter
|
|
|
ATVI
6
DELISTED
Activision Blizzard
ATVI
| $4.68M | 7.04% |
50,000
-39,202
| -44% | -$3.58M |
2022 Q3
4 quarters
|
|
7
Turtle Beach Corp
TBCH
$278M
| $4.22M | 6.34% |
465,000
| – | – |
2021 Q2
9 quarters
|
|
|
8
InterDigital
IDCC
$8.32B
| $2.61M | 3.92% |
32,500
-19,300
| -37% | -$1.68M |
2023 Q1
2 quarters
|
|
|
9
Pitney Bowes
PBI
$2.31B
| $2.6M | 3.91% |
861,016
-153,016
| -15% | -$524K |
2020 Q3
12 quarters
|
|
|
10
DELISTED
Enfusion, Inc.
ENFN
| $2.34M | 3.52% |
+260,706
| New | +$2.48M |
2023 Q3
0 quarters
|
|
11
Owlet
OWLT
$122M
| $793K | 1.19% |
177,007
-1
| -0% | -$4 |
2021 Q4
7 quarters
|
|
|
BKI
12
DELISTED
Black Knight, Inc. Common Stock
BKI
| – | – |
-116,275
| Closed | -$6.94M | – |
|
|
AFTR.U
13
DELISTED
AfterNext HealthTech Acquisition Corp Units
AFTR.U
| – | – |
-850,000
| Closed | -$8.87M | – |
|
|
AUD
14
DELISTED
Audacy, Inc.
AUD
| – | – |
-16,268
| Closed | -$35K | – |
|
Similar funds
IVMX
FA
ROC
E
MCMI
LCM
ACM
GIM
Anqa Management's Q3 2023 Portfolio in Review
As of Q3 2023, Anqa Management held 14 positions worth $66.5M, down 26% from $89.7M the previous quarter. Its ten largest holdings account for 99% of the portfolio.
Anqa Management withdrew a net $18.7M in Q3 2023, closing 3 positions and reducing 4 holdings. Its most notable exit was AfterNext HealthTech Acquisition Corp Units, an estimated $8.87M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 35% of assets, up from 29% a quarter earlier, followed by Technology and Communication Services.
Against the trend, Anqa Management opened a new position in Enfusion, Inc. worth $2.34M.
- Anqa Management's largest Q3 2023 buy was Enfusion, Inc.: 260,706 shares worth $2.34M.
- Anqa Management added most to Illumina in Q3 2023, an estimated $423K increase.
- Anqa Management's biggest Q3 2023 reduction was Activision Blizzard, cutting an estimated $3.58M.
- Anqa Management fully exited AfterNext HealthTech Acquisition Corp Units in Q3 2023, selling an estimated $8.87M.
- Anqa Management's ten largest holdings make up 99% of its $66.5M portfolio in Q3 2023.
- Anqa Management opened 1 new position and closed 3 in Q3 2023.
- Anqa Management's portfolio value fell 26% quarter-over-quarter to $66.5M.
Based on Anqa Management's 13F filing for Q3 2023, filed 13 Nov 2023.